$0.51 6.3%
NIVF Stock Price vs. AI Score
Data gathered: November 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About NewGenIvf Group

NewGenIvf Limited provides fertility services in Thailand, Cambodia, and Kyrgyzstan.


NewGenIvf Group
Price $0.51
Target Price Sign up
Volume 787,840
Market Cap $7.1M
Dividend Yield 0%
PE Ratio 69.86
Analyst Rating 0% buy
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24000-960,000-960,000
Q4 '23000-960,000-1.3M-0.256
Q3 '23000130,000130,0000.023
Q2 '2300085,00085,0000.016
Q1 '2300052,00052,0000.010

What is the Market Cap of NewGenIvf Group?

The Market Cap of NewGenIvf Group is $7.1M.

What is NewGenIvf Group's PE Ratio?

As of today, NewGenIvf Group's PE (Price to Earnings) ratio is 69.86.

What is the current stock price of NewGenIvf Group?

Currently, the price of one share of NewGenIvf Group stock is $0.51.

How can I analyze the NIVF stock price chart for investment decisions?

The NIVF stock price chart above provides a comprehensive visual representation of NewGenIvf Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling NewGenIvf Group shares. Our platform offers an up-to-date NIVF stock price chart, along with technical data analysis and alternative data insights.

Does NIVF offer dividends to its shareholders?

As of our latest update, NewGenIvf Group (NIVF) does not offer dividends to its shareholders. Investors interested in NewGenIvf Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of NewGenIvf Group?

Some of the similar stocks of NewGenIvf Group are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.